The Exec. Vice Chairman of Hemispherx Biopharma Inc (NYSE MKT: HEB) is Buying Shares (Analyst Ratings)
Today, the Exec. Vice Chairman of Hemispherx Biopharma Inc (HEB), Thomas Equels, bought shares of HEB for $118.5K. Following this transaction Thomas Equels’ holding in the company was increased by 2.16% to a total of $5.62 million. Currently, Hemispherx Biopharma Inc has an average volume of 213.3K.
Friday 6/21 Insider Buying Report: LOW, IMMU (Nasdaq.com)
On Wednesday, Lowe’s Companies’ EVP, Supply Chain, Donald Frieson, made a $200,342 purchase of LOW, buying 2,030 shares at a cost of $98.69 a piece. So far Frieson is in the green, up about 4.3% on their purchase based on today’s trading high of $102.96. Lowe’s Companies Inc is trading off about 0.4% on the day Friday. And at Immunomedics, there was insider buying on Thursday, by Chief Quality Officer Bryan Ball who purchased 5,000 shares at a cost of $13.35 each, for a total investment of $66,750. Immunomedics, is trading off about 2.8% on the day Friday. Investors have the opportunity to bag IMMU even cheaper than Ball did, with the stock changing hands as low as $12.91 at last check today which is 3.3% under Ball’s purchase price.
Taipei Court Clears OBI Pharma Execs of Insider Trading (Taipei Times)
The Shilin District Court yesterday found OBI Pharma chairman Michael Chang and four other company executives not guilty of insider trading. The acquittal was based on a lack of clear evidence that Chang, general manager Amy Huang, vice president Hsu Yo-gung, research and development director Yu Cheng-te and administration division manager Liao Tsung-chih committed insider trading, the court said in a statement.
Insiders Roundup: Anaplan, Chubb (Guru Focus)
Rob Ward, director of Anaplan Inc. (PLAN), sold 396,324 shares for an average price of $51.85 per share on June 20. The provider of software infrastructure has a market cap of $6.63 billion and an enterprise value of $6.31 billion. It has insider ownership of 1.36% and institutional ownership of 38.26%. Over the last three months, the stock has risen 34.04%. It is trading 3.11% below its three-month high and 52.87% above its three-month low. Evan G. Greenberg, Chairman and CEO sold 215.648 shares of Chubb Ltd. (CB) for an average price of $148.84 per share on June 19. The company has a market cap of $68.39 billion and an enterprise value of $76.93 billion. Over the last 12 months, the stock has gained 17.88% and is now trading 1.74% below its 52-week high and 24.95% above its 52-week low.
Colliers Accuses CEO of Insider Trading (EuroBuildCEE.com)
WORLD Dylan Taylor has been dismissed as chief executive officer of Colliers real estate services for misconduct including improper trading activity in Colliers securities in breach of his employment obligations. In turn Dylan Taylor has made undisclosed allegations, which he asserts as the basis for a potential constructive dismissal claim. The board has constituted a special committee to oversee an independent review of these claims.
